Monitoring product safety beyond clinical trials – Industry practices
Dr J Vijay Venkatraman, Managing Director & CEO, Oviya MedSafe, details on the need to foster adherence to good…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
The Pill House
Pill House or the pharmacy forms an integral part of the healthcare system. Pharmacies with well-organised practice can go a long…
Building an effective sales pipeline
Mohan G Joshi, International Business Coach and Former President, SCHOTT Glass India outlines the importance of measuring the…
‘Under GDUFA II, FDA has committed to clean up inaccurate, inconsistent and missing…
DuPont Nutrition & Health's regulatory team, from direct participation on joint IPEC and FDA working groups, has the expertise…
AI in pharma: A new perspective
Dipankar Kaul -Head GMP Audits, Asia-Pacific- Novartis Technical Operations, envisages the many ways in which AI can transform…
Pancreatic cancer treatment heads in promising direction
Despite the disappointing history of drug development in pancreatic cancer, the current therapeutic pipeline and clinical…
FlexFactory, life science solutions to drive growth for GE Healthcare
India is a Top 5 market, life sciences is fastest growing segment of GE Healthcare By Viveka Roychowdhury
The art and science of prospecting in the new age
Mohan G Joshi, International Business Coach and Former President, SCHOTT Glass India, expounds on how prospecting has changed and…
‘Pharmaceutical manufacturers must act now to avoid production scheduling clashes’ | Dr…
Pharmaceutical manufacturers must act now to avoid production scheduling clashes as well as technical and cost challenges ahead of…
The disadvantage will be the additional cost involved | SV Veerramani
The advantage of EU FMD implementation may result in better traceability and avoid spurious or non registered drugs
‘Serialisation can analyse business value’ | Shashikant Joag
Existence of Falsified Medicines over the pharmacy counter thus has remained a grave concern for regulators all over the world
‘It is a major step for anti-counterfeiting’ | Parag Kothari
Marketing Authorisation Holders (MAHs) will be required to upload their products serialisation codes to the European Medicines…
EU FMD: Uniform practice for all
In less than four months, by February 9, 2019 the Falsified Medicines Directive (FMD) will be implemented in more than 30…
Pre-authorisation regulatory guidance for marketing of medicines in India
Rajdutt Shekhar Singh, Partner, Singh & Associates, shares insights on ways to effective marketing strategy
Pharma licensing framework and the way forward
Sanjay Sharma, Head-Lifesciences, NCF, UK; Ritu Hasija, Director Corporate and Girish Arora, Managing Director, Alniche…
Lupin’s Nagpur plant gears for future growth
During a recent plant visit to Lupin’s Nagpur facility, Swati Rana in an interaction with
Rajiv Desai, Executive VP - Corporate…
India adopts proactive approach in adopting biosimilars to bring down cost
Introduction of new drugs in the form of biosimilars will bring in new drug delivery system. The Indian pharma companies are…
Behind all the hype and hoopla about biosimilars
Looking at the pipeline of biosimilars, India shall remain a major market for biosimilars. Dr Siddharth Dutta, Associate Vice…
Good medicines come in quality packages
In the third of a series of six articles, Organisation of Pharmaceutical Producers of India (OPPI) launches the Know Your Pill…
Direct to consumer advertising of medicines and medical devices — a call for action!
Dr Milind Antani, Anay Shukla and Darren Punnen from Nishith Desai Associates, give an insight on the scope of laws that regulate…